The identification of the oncogene, BRF2, specific to lung squamous cell carcinoma suggests that genetic activation of this oncogene could be used as an identification marker for this type of lung cancer.
Too little of a protein called neogenin results in a smaller skeleton during development and sets the stage for a more fragile bone framework lifelong, Medical College of Georgia researchers report.
Scientists have shown that a variant form of a fluorescent protein originally isolated from a reef coral has excellent properties as a marker protein for super-resolution microscopy in live cells.
Ben-Gurion University of the Negev researchers reveal in a new, large-scale study that "normal" blood pressure at age 17 can still predict hypertension at early adulthood and that teenage boys are three to four times more likely to develop high blood pressure in early adulthood than girls.
Dynavax Technologies Corporation reported completing enrollment and the first immunizations of 39 subjects enrolled in its Phase 1 study of the company's Universal Flu vaccine.
Tibotec Pharmaceuticals has submitted a New Drug Application to the U.S. Food and Drug Administration for TMC278 (rilpivirine), an investigational non-nucleoside reverse transcriptase inhibitor, for once-daily use in treatment-naïve HIV-1-infected adults.
Merck KGaA announced that the U.S. Food and Drug Administration has accepted for filing the New Drug Application for cladribine tablets as a therapy for relapsing forms of multiple sclerosis.
Using chemical "nanoblasts" that punch tiny holes in the protective membranes of cells, researchers have demonstrated a new technique for getting therapeutic small molecules, proteins and DNA directly into living cells.
CVS Caremark Corp. said it struck a large pharmacy benefit management services contract with health insurer Aetna Inc., but confidence fell as the pharmacy chain reported weaker earnings and trimmed its profit forecast.
Genetix, a leading provider of solutions for imaging and image analysis, announces the availability of an independent, peer-reviewed publication comparing cytotoxicity testing using its CloneSelect Imager system against the conventional, widely-used, colorimetric MTT assay.
GE Healthcare has launched the Biacore T200, designed to deliver exceptional sensitivity in the measurement of high-quality kinetic, affinity, concentration, specificity, and thermodynamic interaction data, in real time.
AbD Serotec has signed an exclusive license agreement with University College London Business PLC to provide AbD Serotec with access to a potent anti-PTH antibody for commercial use in research and diagnostic applications.
NovImmune, an antibody-focused research and development biotech company, has entered into an exclusive licensing agreement with Genentech Inc. for a proprietary anti-IL-17 fully human monoclonal antibody, and access to back-up antibodies.
The mechanism by which a herpes virus invades cells has always been a mystery to scientists, but now researchers have revealed that the unusual structure of a key member of the protein complex allows the herpes virus to enter cells.